Annual SGA
$7.00 M
-$6.10 M-46.55%
December 31, 2023
Summary
- As of February 8, 2025, ABVC annual SGA is $7.00 million, with the most recent change of -$6.10 million (-46.55%) on December 31, 2023.
- During the last 3 years, ABVC annual SGA has fallen by -$1.42 million (-16.82%).
- ABVC annual SGA is now -46.55% below its all-time high of $13.10 million, reached on December 31, 2022.
Performance
ABVC SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$301.20 K
-$752.00 K-71.40%
September 30, 2024
Summary
- As of February 8, 2025, ABVC quarterly SGA is $301.20 thousand, with the most recent change of -$752.00 thousand (-71.40%) on September 30, 2024.
- Over the past year, ABVC quarterly SGA has dropped by -$1.70 million (-84.94%).
- ABVC quarterly SGA is now -95.10% below its all-time high of $6.15 million, reached on December 31, 2021.
Performance
ABVC Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$275.69 M
-$8.24 M-3.08%
September 30, 2024
Summary
- As of February 8, 2025, ABVC TTM SGA is -$275.69 million, with the most recent change of -$8.24 million (-3.08%) on September 30, 2024.
- Over the past year, ABVC TTM SGA has dropped by -$282.90 million (-3922.51%).
- ABVC TTM SGA is now -527034.23% below its all-time high of -$52.30 thousand.
Performance
ABVC TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
ABVC Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -46.5% | -84.9% | -3922.5% |
| 3 y3 years | -16.8% | -83.3% | -2961.7% |
| 5 y5 years | +867.5% | -83.3% | -2961.7% |
ABVC Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.5% | at low | -95.1% | at low | -121.4% | at low |
| 5 y | 5-year | -46.5% | +126.5% | -95.1% | at low | -382.1% | at low |
| alltime | all time | -46.5% | >+9999.0% | -95.1% | +112.1% | <-9999.0% | at low |
ABVC BioPharma Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $301.20 K(-71.4%) | $6.48 M(-20.8%) |
| Jun 2024 | - | $1.05 M(-68.8%) | $8.18 M(-6.4%) |
| Mar 2024 | - | $3.38 M(+92.7%) | $8.74 M(+24.8%) |
| Dec 2023 | $7.00 M(-46.6%) | $1.75 M(-12.4%) | $7.00 M(-2.9%) |
| Sep 2023 | - | $2.00 M(+24.0%) | $7.21 M(-16.7%) |
| Jun 2023 | - | $1.61 M(-1.6%) | $8.65 M(-2.3%) |
| Mar 2023 | - | $1.64 M(-16.4%) | $8.86 M(-32.4%) |
| Dec 2022 | $13.10 M(+18.6%) | $1.96 M(-43.0%) | $13.10 M(-24.2%) |
| Sep 2022 | - | $3.44 M(+89.3%) | $17.29 M(+10.5%) |
| Jun 2022 | - | $1.82 M(-69.1%) | $15.65 M(+0.7%) |
| Mar 2022 | - | $5.88 M(-4.3%) | $15.54 M(+40.6%) |
| Dec 2021 | $11.05 M(+31.3%) | $6.15 M(+240.4%) | $11.05 M(+14.7%) |
| Sep 2021 | - | $1.81 M(+5.8%) | $9.63 M(+6.0%) |
| Jun 2021 | - | $1.71 M(+22.5%) | $9.09 M(+5.0%) |
| Mar 2021 | - | $1.39 M(-70.5%) | $8.66 M(+2.8%) |
| Dec 2020 | $8.42 M(+172.3%) | $4.73 M(+274.6%) | $8.42 M(+81.3%) |
| Sep 2020 | - | $1.26 M(-1.2%) | $4.64 M(+5.0%) |
| Jun 2020 | - | $1.28 M(+10.7%) | $4.42 M(+18.7%) |
| Mar 2020 | - | $1.15 M(+21.2%) | $3.73 M(+20.5%) |
| Dec 2019 | $3.09 M(+327.1%) | $951.70 K(-8.6%) | $3.09 M(+90.0%) |
| Sep 2019 | - | $1.04 M(+79.7%) | $1.63 M(+75.3%) |
| Jun 2019 | - | $579.50 K(+11.6%) | $928.10 K(+13.6%) |
| Mar 2019 | - | $519.40 K(-201.3%) | $817.20 K(+12.9%) |
| Dec 2018 | $723.90 K(-25.1%) | -$512.80 K(-249.9%) | $723.90 K(-53.1%) |
| Sep 2018 | - | $342.00 K(-27.0%) | $1.54 M(+4.4%) |
| Jun 2018 | - | $468.60 K(+10.0%) | $1.48 M(+25.1%) |
| Mar 2018 | - | $426.10 K(+38.7%) | $1.18 M(+22.2%) |
| Dec 2017 | $967.10 K(+14.4%) | $307.10 K(+11.1%) | $967.10 K(+14.4%) |
| Sep 2017 | - | $276.30 K(+60.6%) | $845.20 K(-30.5%) |
| Sep 2017 | $845.20 K(-15.3%) | - | - |
| Jun 2017 | - | $172.00 K(-18.8%) | $1.22 M(-8.8%) |
| Mar 2017 | - | $211.70 K(+14.3%) | $1.33 M(+8.4%) |
| Dec 2016 | - | $185.20 K(-71.4%) | $1.23 M(+17.5%) |
| Sep 2016 | $997.30 K | $647.80 K(+124.1%) | $1.05 M(+162.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2016 | - | $289.10 K(+166.0%) | $399.40 K(+262.1%) |
| Mar 2016 | - | $108.70 K(+6693.8%) | $110.30 K(+6793.8%) |
| Dec 2015 | - | $1600.00(-99.8%) | $1600.00(-99.9%) |
| Jun 2011 | - | $773.40 K(+134.8%) | $1.82 M(+31.2%) |
| Mar 2011 | - | $329.40 K(-11.1%) | $1.39 M(-6.8%) |
| Dec 2010 | - | $370.60 K(+8.0%) | $1.49 M(-22.0%) |
| Sep 2010 | $1.90 M(-61.2%) | $343.30 K(+0.5%) | $1.90 M(-17.9%) |
| Jun 2010 | - | $341.70 K(-20.6%) | $2.32 M(-13.0%) |
| Mar 2010 | - | $430.60 K(-45.4%) | $2.67 M(-13.2%) |
| Dec 2009 | - | $788.60 K(+3.9%) | $3.07 M(-37.5%) |
| Sep 2009 | $4.91 M(-8.7%) | $758.90 K(+10.4%) | $4.91 M(-5.7%) |
| Jun 2009 | - | $687.70 K(-17.6%) | $5.21 M(-10.7%) |
| Mar 2009 | - | $834.30 K(-68.3%) | $5.84 M(-11.0%) |
| Dec 2008 | - | $2.63 M(+148.6%) | $6.56 M(+21.9%) |
| Sep 2008 | $5.38 M(+20.7%) | $1.06 M(-19.6%) | $5.38 M(+24.5%) |
| Jun 2008 | - | $1.32 M(-15.3%) | $4.32 M(+19.5%) |
| Mar 2008 | - | $1.55 M(+6.9%) | $3.62 M(+74.3%) |
| Dec 2007 | - | $1.45 M(+138.2%) | $2.08 M(-527.3%) |
| Sep 2007 | $4.46 M(>+9900.0%) | - | - |
| Jun 2007 | - | $610.20 K(+4943.0%) | -$485.80 K(-55.4%) |
| Mar 2007 | - | $12.10 K(-100.5%) | -$1.09 M(-0.3%) |
| Dec 2006 | $26.80 K(+52.3%) | -$2.49 M(-280.1%) | -$1.09 M(-178.1%) |
| Sep 2006 | - | $1.38 M(>+9900.0%) | $1.40 M(+6254.5%) |
| Jun 2006 | - | $7600.00(-8.4%) | $22.00 K(+18.9%) |
| Mar 2006 | - | $8300.00(-1760.0%) | $18.50 K(+5.7%) |
| Dec 2005 | $17.60 K(+20.5%) | -$500.00(-107.6%) | $17.50 K(+21.5%) |
| Sep 2005 | - | $6600.00(+61.0%) | $14.40 K(-5.9%) |
| Jun 2005 | - | $4100.00(-43.8%) | $15.30 K(-17.3%) |
| Mar 2005 | - | $7300.00(-302.8%) | $18.50 K(+26.7%) |
| Dec 2004 | $14.60 K(+24.8%) | -$3600.00(-148.0%) | $14.60 K(-19.8%) |
| Sep 2004 | - | $7500.00(+2.7%) | $18.20 K(+70.1%) |
| Jun 2004 | - | $7300.00(+114.7%) | $10.70 K(+214.7%) |
| Mar 2004 | - | $3400.00 | $3400.00 |
| Dec 2003 | $11.70 K | - | - |
FAQ
- What is ABVC BioPharma annual SGA?
- What is the all time high annual SGA for ABVC BioPharma?
- What is ABVC BioPharma annual SGA year-on-year change?
- What is ABVC BioPharma quarterly SGA?
- What is the all time high quarterly SGA for ABVC BioPharma?
- What is ABVC BioPharma quarterly SGA year-on-year change?
- What is ABVC BioPharma TTM SGA?
- What is the all time high TTM SGA for ABVC BioPharma?
- What is ABVC BioPharma TTM SGA year-on-year change?
What is ABVC BioPharma annual SGA?
The current annual SGA of ABVC is $7.00 M
What is the all time high annual SGA for ABVC BioPharma?
ABVC BioPharma all-time high annual SGA is $13.10 M
What is ABVC BioPharma annual SGA year-on-year change?
Over the past year, ABVC annual SGA has changed by -$6.10 M (-46.55%)
What is ABVC BioPharma quarterly SGA?
The current quarterly SGA of ABVC is $301.20 K
What is the all time high quarterly SGA for ABVC BioPharma?
ABVC BioPharma all-time high quarterly SGA is $6.15 M
What is ABVC BioPharma quarterly SGA year-on-year change?
Over the past year, ABVC quarterly SGA has changed by -$1.70 M (-84.94%)
What is ABVC BioPharma TTM SGA?
The current TTM SGA of ABVC is -$275.69 M
What is the all time high TTM SGA for ABVC BioPharma?
ABVC BioPharma all-time high TTM SGA is -$52.30 K
What is ABVC BioPharma TTM SGA year-on-year change?
Over the past year, ABVC TTM SGA has changed by -$282.90 M (-3922.51%)